Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Versant Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Versant Ventures

Versant Ventures

Operating

Versant Ventures: A leading healthcare investment firm, focusing on novel therapeutic biotechnology.

Location
San Francisco, CA, US
Founded
1999
Firm
Compare
Portfolio
Employees
Website

Versant Ventures is a prominent healthcare investment firm specializing in biotechnology companies that focus on discovering and developing novel therapeutics. With $2.4 billion under management, the firm typically invests in early to mid-stage rounds, including Series A, B, and C. Versant Ventures operates globally with multiple locations and has a strong emphasis on leveraging scientific advancements to drive innovation in healthcare.

Notable portfolio companies include Century Therapeutics, Black Diamond Therapeutics, and Gritstone bio. The firm boasts an experienced team with extensive backgrounds in venture capital, pharmaceuticals, and biotechnology. Versant Ventures offers unique value-add services through its Discovery Engines, which consist of in-house teams of multi-disciplinary scientists working in state-of-the-art laboratory facilities to support the launch of novel biotech ventures.

Versant Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments174
Current Portfolio Count64
Total Portfolio Exits10

Top Investment Stages

Series A48 (31.2%)
Series B42 (27.3%)
Series C27 (17.5%)
Series D19 (12.3%)
Series Unknown18 (11.7%)

Stage Mix

Series A 31%Series B 27%Series C 18%Series D 12%Series Unknown 12%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Gate Bioscience logo

Gate Bioscience

Tentarix Biotherapeutics logo

Tentarix Biotherapeutics

Nexo Therapeutics logo

Nexo Therapeutics

Kate Therapeutics logo

Kate Therapeutics

Belharra Therapeutics logo

Belharra Therapeutics

Launchpad Therapeutics logo

Launchpad Therapeutics

Iecure logo

Iecure

Jnana Therapeutics logo

Jnana Therapeutics

Tempest Therapeutics logo

Tempest Therapeutics

Ventus Therapeutics logo

Ventus Therapeutics

Nested Therapeutics logo

Nested Therapeutics

Coda Biotherapeutics logo

Coda Biotherapeutics

ViaLase logo

ViaLase

858 Therapeutics logo

858 Therapeutics

Lycia Therapeutics logo

Lycia Therapeutics

Lenz Therapeutics logo

Lenz Therapeutics

Stablix logo

Stablix

Capsida Biotherapeutics logo

Capsida Biotherapeutics

Century Therapeutics logo

Century Therapeutics

Vividion Therapeutics logo

Vividion Therapeutics

Pipeline Therapeutics logo

Pipeline Therapeutics

Gritstone bio logo

Gritstone bio

Aligos Therapeutics logo

Aligos Therapeutics

Black Diamond Therapeutics logo

Black Diamond Therapeutics

Nuvaira logo

Nuvaira

Versant Ventures - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end